Explore Other Related Events
The Gene Therapy Event Series spans in-depth content for each role and specification in gene therapy drug development, so you can curate your event calendar to meet industry leaders most relevant to your area of expertise across the year. Download our Partnership Prospectus now to find out more.
As an increasing number of genetic therapies advance through the development stages, companies are recognizing the importance of effective patient engagement in the success of gene therapy initiatives.
Gene therapy companies are seeking partnerships with organizations that not only understand but actively integrate patient-centric values within gene therapy services. Such collaborations are instrumental in bolstering and streamlining the development pipelines of these companies.
By aligning with us, you gain a distinctive platform to showcase how your services resonate with gene therapy companies aiming to incorporate the patient voice into clinical trials and gene therapy development.
Reach out to us today to discover more about how we can collaboratively forge a tailored partnership to support your business development objectives.
2024 Partners
Seques is the first healthcare communications agency to specialize in cell and gene therapies. We have been working exclusively with pharmaceutical and biotechnology companies developing and commercializing cell and gene therapies in a range of therapy areas for over 5 years. Our team includes individuals with academic genetic experience, including many who have practical experience of gene editing technologies. We combine this expertise with a global agency platform and extensive experience in healthcare communications. Our experience is broad, having supported companies with products in early phase clinical development, as well as those commercializing cell and gene therapies for the first time.
Origins are global patient focused specialists. We transform our clients’ strategies and results through connecting them with the power of the patient. Our end-to-end patient focused expertise delivers significant incremental value across patient engagement, medical, clinical development, regulatory approval and market access around the globe. We enable our clients to truly consider and include the patient and caregiver experience, perspective and unmet needs, and realise greater success as a result.
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With more than 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
What do the Experts need?
- Clinical CROs – There is an increasing need for expertize in patient recruitment, retention and engagement as more trials progress into the clinic. Seize this opportunity to showcase improve communication, education, and support for patients enrolled in gene therapy trials, ultimately leading to better engagement.
- Consultants - Ensuring patient engagement strategies are ethically sound adhere to guidelines related to informed consent, patient autonomy, and protection of vulnerable populations is vital. Take this opportunity to demonstrate how you can assess potential risk and develop clear communication about gene therapies.
- Medical Communications - Translating technical information into patient-friendly materials, such as brochures, videos, and websites, making it more accessible for potential trial participants can be a challenge. Demonstrate how you assist gene therapy companies in crafting clear and compelling messages about the gene therapy, trial objectives, and facilitating better engagement with patients.
- Patient Support Platforms - Establishing a comprehensive and technology-driven approach to support trial participants is vital to enhance communication, provide educational resources, offer real-time support, and contribute to the overall success of gene therapy trials by fostering a positive and engaged patient experience.
And so much more!
Why Partner in 2025?
Thought Leadership
Present on the main agenda with Krystal Biotech, Ultragenyx Pharmaceutical & Regeneron Pharmaceuticals to demonstrate your expertize and position yourself as the market leader
Lead Generation
Secure unmissable face time with key decision makers through our dedicated speed networking and pre-organized 1-2-1 meetings with key decision makers
Elevate Brand Awareness
Increase market share through advertising during pre-conference and main conference days
Showcase your work
To key decision makers, including CMOs, and Directors of Patient Advocacy and Engagement. Give potential customers hands-on insight into your resources in the exhibition room